General cryosurgery, state of the arts, trends and prospects.

Author(s) : TANAKA S.

Type of article: Article

Summary

Applying low temperatures to medicine, particularly for the treatment of malignant lesions, is one of the "High Energy Treatments", with the best cost/benefit ratio. Tissue temperatures of -50 deg C or tissue impedance of 500 kilo-ohms can destroy the tumour. Cryosurgery provides two prominent services: in situ destruction of tumours which otherwise would be difficult to treat, and potential tumour-specific immunotherapy. Thus, cryosurgery should be incorporated into the multidisciplinary regimen against cancer. A total of 4,808 patients received cryosurgery from July 1968 to June 1991, 403 with malignant and 4,405 with benign lesions. The overall 1-year survival rate of the primary cancer patients was 63.3%; the 3-year rate, 47.7%; and the 5-year rate, 43.8%; even though most patients were suffering from advanced diseases.

Details

  • Original title: General cryosurgery, state of the arts, trends and prospects.
  • Record ID : 1994-0584
  • Languages: English
  • Subject: General information
  • Source: Low Temperature Medicine - vol. 18 - n. 2
  • Publication date: 1992/06
  • Document available for consultation in the library of the IIR headquarters only.

Links


See other articles in this issue (2)
See the source